William G Couser Selected Research

Complement Component 6 Deficiency

2/2005	C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria.
11/2004	C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William G Couser Research Topics

Disease

10	Proteinuria 01/2020 - 04/2002
8	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2020 - 01/2003
3	Glomerulonephritis 11/2015 - 03/2003
3	Chronic Renal Insufficiency 02/2011 - 02/2005
3	Renal Insufficiency (Renal Failure) 11/2006 - 07/2003
3	Fibrosis (Cirrhosis) 11/2006 - 04/2002
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2011 - 07/2003
2	Inflammation (Inflammations) 11/2006 - 07/2003
2	Sclerosis 11/2006 - 05/2005
2	Hypertrophy 11/2006 - 01/2005
2	Hyperglycemia 12/2005 - 04/2003
2	Kidney Diseases (Kidney Disease) 04/2005 - 04/2005
2	Nephrosis 02/2005 - 07/2003
2	Complement Component 6 Deficiency 02/2005 - 11/2004
2	Neoplasms (Cancer) 07/2003 - 12/2002
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Immune System Diseases (Immune Disorders) 06/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 06/2017
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2015
1	Nephritis 03/2012
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 03/2012
1	Lupus Nephritis 03/2012
1	Infections 03/2012
1	IGA Glomerulonephritis (IGA Nephropathy) 03/2012
1	Vascular Diseases (Vascular Disease) 02/2011
1	Hypoxia (Hypoxemia) 12/2005
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2004
1	Acute Kidney Injury (Acute Renal Failure) 05/2003
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2003
1	Nephrolithiasis 01/2003

Drug/Important Bio-Agent (IBA)

7	Complement System Proteins (Complement)IBA 03/2012 - 04/2002
6	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2006 - 04/2002
3	Cell Cycle ProteinsIBA 11/2006 - 01/2003
3	Proteins (Proteins, Gene)FDA Link 12/2005 - 04/2004
2	Immunoglobulin G (IgG)IBA 01/2020 - 06/2017
2	AntigensIBA 06/2017 - 09/2005
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2015 - 03/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2005 - 07/2002
2	Streptozocin (Streptozotocin)FDA Link 02/2005 - 04/2003
2	AlbuminsIBA 01/2004 - 07/2003
1	Phospholipase A2 ReceptorsIBA 01/2020
1	AutoantibodiesIBA 06/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2017
1	Peroxidase (Myeloperoxidase)IBA 11/2015
1	AutoantigensIBA 03/2012
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2012
1	Biomarkers (Surrogate Marker)IBA 02/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2005
1	Calcimycin (A23187)IBA 12/2005
1	Endoplasmic Reticulum Chaperone BiPIBA 12/2005
1	TunicamycinIBA 12/2005
1	glucose-regulated proteinsIBA 12/2005
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 09/2005
1	Neprilysin (Neutral Endopeptidase)IBA 09/2005
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2005
1	GlycogenIBA 02/2005
1	SodiumIBA 02/2005
1	Mitogen-Activated Protein Kinase 3IBA 01/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2004
1	Cyclin D1IBA 04/2004
1	CyclinsIBA 04/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2003
1	CytokinesIBA 07/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2003
1	Complement Inactivating AgentsIBA 03/2003
1	Calcium OxalateIBA 01/2003
1	CalciumIBA 01/2003
1	Cyclin B1IBA 01/2003
1	Histones (Histone)IBA 01/2003
1	OsteopontinIBA 07/2002

Therapy/Procedure

3	Therapeutics 12/2011 - 05/2003
2	Transplantation 04/2005 - 04/2005
1	Nephrectomy 12/2002